搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
capitalbrief
3 小时
Dow ends week at record high after tame inflation report
The blue-chip Dow Jones Industrial Average closed at a record high on Friday as a subdued US inflation report lifted ...
9 小时
on MSN
This FDA-approved drug promises a new way to treat schizophrenia
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
stockhead
14 小时
Market Highlights: All eyes on another ASX record, and why investors could pile on stocks ...
ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.
Opinion
eNCA
15 小时
Opinion
New drug for schizophrenics has experts excited
WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...
The Pharma Letter
15 小时
The week in pharma: action, reaction and insight – week to September 27
Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...
devdiscourse
20 小时
A Snapshot of Current Health Developments
Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...
Health and Me on MSN
21 小时
Breakthrough in Schizophrenia Treatment: FDA Approves Cobenfy
New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈